US 7150875
Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine
granted A61KA61K39/00A61P
Quick answer
US patent 7150875 (Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K39/00, A61P, A61P33/06